selected scholarly activity
-
conferences
- Impact of health care professional interventions on completion of therapy in patients receiving high-dose interferon-alfa 2b adjuvant therapy for high-risk melanoma.. Journal of Clinical Oncology. e20038-e20038. 2014
- Dose reduced first-line capecitabine monotherapy in older and less fit patients with advanced colorectal cancer (ACRC). Journal of Clinical Oncology. 3577-3577. 2005
- Prognostication using serum levels of components of the folate metabolic pathway in patients (PTS) treated with capecitabine for advanced colorectal cancer (ACRC).. Journal of Clinical Oncology. 310S-310S. 2004
-
journal articles
- Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review. Surgical Oncology. 54:102077-102077. 2024
- An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent. Clinical Oncology. 36:243-253. 2024
- Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada. Clinical Colorectal Cancer. 23:46-57.e4. 2024
- Restructuring Skin Cancer Care in Ontario: A Provincial Plan. Current Oncology. 28:1183-1196. 2021
- Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review. Cancer Treatment Reviews. 87:102032-102032. 2020
- Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Cutaneous or Mucosal Melanoma: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline. Current Oncology. 27:43-52. 2020
- Staging and surgical approaches in gastric cancer: A systematic review. Cancer Treatment Reviews. 63:104-115. 2018
- Staging and Surgical Approaches in Gastric Cancer: A Clinical Practice Guideline. Current Oncology. 24:324-331. 2017
- Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer. 16:28-40. 2013